Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Stärke
Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Packungsgröße
Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Form
Libtayo-H-C-PSUSA-00010780-202209: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.